semaglutide therapy cincinnati Weight Loss At-Home Medical Weight Loss Injections

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

Dr Gregom Sng and Dr Chew Chun Yang from Parkway Shenton explain whos suitable, how these medications work, and what results to expect.

Learn when side effects improve and effective management strategies

Ultrasound assessments could improve risk stratification for perioperative management

The thigh is an approved injection site for semaglutide therapy, offering convenient self-administration when rotated properly

Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation